Delivery Order SPE2DB22D1106-SPE2DB25FFDX2
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) prefilled pens with a firm fixed price ceiling value of $5,468.60. The contract, which is not set-aside, represents a single delivery order with an ultimate completion date of August 19, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded and...
- The Defense Logistics Agency awarded a $13,541.70 delivery order to AmerisourceBergen Drug Corp for Ozempic (0.25-0.5 mg/dose pen, 3ml) on July 30, 2025, with a completion date of July 31, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) pre-filled pens with a ceiling value of $3,519.05. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical product will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Ozempic (0.25-0.5 mg/dose pen, 3ml) with a ceiling value of $26,032.94. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under a larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pens in 3 mL formulations, with a ceiling value of $4,018.44. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of August 15, 2025. The order will be fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) prefilled pens, with a contract ceiling value of $6,878.27 and an ultimate completion date of July 22, 2025. This competitively awarded, firm fixed-price delivery order was placed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor vehicle valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) prefilled syringes with a ceiling value of $7,519.92. This is a firm fixed price delivery order with an ultimate completion date of July 30, 2025, and performance will be executed from the vendor's location in Conshohocken, Pennsylvania. The contract represents a non-competitive set-aside award, indicating that AmerisourceBergen was selected...
- The Defense Logistics Agency awarded a delivery order valued at $11,180.43 to AmerisourceBergen Drug Corp for the supply of Ozempic (0.25-0.5 mg/dose) pen injectors in 3 mL formulations. This firm fixed-price delivery order, awarded on July 25, 2025, with an ultimate completion date of July 28, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was competitively procured with no set-aside designation and...
- The Defense Logistics Agency awarded a delivery order valued at $8,441.00 to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens (3mL) on August 18, 2025, with an ultimate completion date of August 19, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials, with a contract ceiling value of $34,924.93. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's existing...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFDX2Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) prefilled pens on August 18, 2025, with a ceiling value of $5,204.26. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, performed from the company's Conshohocken, Pennsylvania facility. The award represents a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive pharmaceutical supply vehicle for military and federal healthcare systems worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains extensive experience fulfilling federal medical procurement requirements across multiple therapeutic domains. The company's DLA IDC encompasses a broad portfolio of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. This specific delivery order for Ozempic, a diabetes treatment medication, reflects the company's ongoing role in supporting Defense Health Agency requirements and broader military healthcare operations through the flexible IDC vehicle, which enables responsive delivery of critical pharmaceutical commodities to government customers globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.2k | 8/18/25 |